Tumor electrophysiological abnormalities, characterized by membrane imaginable dysregulation, ion transmission web remodeling, and microenvironmental signaling interactions, are captious drivers of malignancy. A cardinal characteristic is nan depolarization of nan transmembrane resting imaginable (Vm), a hallmark of tumor cells that promotes proliferation, maintains crab stem compartment (CSCs) undifferentiated states, and facilitates metastatic remodeling. These abnormalities widen beyond nan plasma membrane: CSCs grounds mitochondrial membrane imaginable hyperpolarization pinch a pronounced pH gradient betwixt nan matrix and cytoplasm, enhancing their malignant properties.
Tumor-specific "ion transmission fingerprints" interact pinch cardinal signaling pathways to thrust malignancy. TRPV1, for instance, acts bidirectionally: successful aggregate myeloma, its inhibition induces endoplasmic reticulum accent and mitochondrial calcium overload, synergizing pinch bortezomib to flooded supplier resistance. In gastric cancer, debased TRPV1 look reduces Ca²⁺/CaMKKβ/AMPK activity, relieving cyclin D1 and MMP2 inhibition to beforehand penetration and correlate pinch mediocre prognosis. In medulloblastoma, Kir2.1 interacts pinch Adam10 via non-ion transmission mechanisms, enhancing Notch2 cleavage and activating nan C-Myc/Slug axis, driving EMT, metastasis, and reducing 5-year survival. The tumor microenvironment's electrophysiological remodeling besides modulates immunosuppression: elevated interstitial potassium reprograms tumor-associated macrophages (TAMs) via Kir2.1, suppressing inflammatory genes while promoting immunosuppressive facet secretion. In glioblastoma, nan EAG2-Kvβ2 analyzable astatine nan tumor-brain interface enhances proliferation, invasion, and chemoresistance done calcium transient modulation.
Precision therapies targeting these abnormalities person precocious significantly. Structure-guided narcotics for illustration K90-114TAT, designed from Kvβ2's crystal structure, inhibit EAG2-Kvβ2 interactions, reducing tumor size successful glioma models, including temozolomide-resistant subtypes. Compounds exploiting electrochemical gradients, specified arsenic nan K⁺/H⁺ transporter Compound 2, target mitochondrial pH gradients and hyperpolarization successful CSCs, triggering ROS surges to destruct CD133⁺ ovarian CSCs. Electric section therapies (TTFields) disrupt mitosis by interfering pinch microtubules and Septin, while expanding membrane and blood-brain obstruction permeability to heighten supplier delivery; combining TTFields pinch temozolomide improves glioblastoma prognosis. Multimodal approaches, for illustration Kir2.1 inhibitors pinch PD-1 antibodies to reverse TAM M2 polarization, aliases irreversible electroporation (IRE) pinch TLR3/9 agonists and PD-1 blockade to boost CD8⁺ T compartment cytotoxicity, show beardown synergy.
Clinical applications person made strides. A pan-European study connected electrochemotherapy (ECT) for cutaneous malignancies reported precocious consequence rates, pinch Kaposi's sarcoma and basal compartment carcinoma responding best. High-frequency irreversible electroporation (H-FIRE) efficaciously ablates localized prostate crab while preserving usability pinch mild complications. Nanodelivery systems for illustration M-UCN-T merchandise nitric oxide successful consequence to near-infrared ray and glutathione, activating endoplasmic reticulum TRPV1 to induce calcium merchandise and immunogenic compartment death, suppressing gliomas without systemic toxicity.
Translational challenges persist: IRE pinch γδ T-cell therapy prolongs endurance but risks gastrointestinal bleeding and biliary obstruction, limiting usage successful high-risk patients. H-FIRE needs larger studies to validate semipermanent efficacy crossed tumors. Future directions see pH-responsive TRPV1 modulator transportation systems targeting nan bony marrow to trim neuropathic pain, move monitoring platforms search immune cells, and precocious nanoparticle systems for illustration M-UCN-T (92% tumor suppression). These innovations purpose to beforehand precision electrophysiological tumor therapy.
English (US) ·
Indonesian (ID) ·